Skip to main content
OpenTrials
Completed

NCT Number: NCT07009301

Pulmonary Embolism Following Viper's Bites: A Case Report

Viper envenomation constitutes a medical emergency predominantly occurring in rural regions, where specific viper species are endemic, with their distribution influenced by climatic variations. The literature describes numerous complications associated with viper bites, including neurological disturbance, hematological abnormalities, and irreversible renal failure.

We report the case of a 65-year-old female patient admitted to the intensive care unit for viper envenomation characterized by extensive local edema. Diagnostic investigations, including laboratory tests and imaging studies, revealed the presence of a bilateral pulmonary embolism. The patient was subsequently treated with antivenom therapy, followed by initiation of low molecular weight heparin. Despite the recognized high risk of viper envenomation described in the literature, the patient experienced an uncomplicated clinical course and was discharged in stable condition with no further complications.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

Female

Study type

Observational

Primary location

University hospital center Mohammed VI of Oujda

Oujda, Morocco

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age above 18years old

Exclusion criteria

  • Not bitten by snakes

Treatment and study plan

Primary outcomes

  1. Evolution of hematological blood test during the ICU stay

    Time frame: From January 2025 to May 2025

Sponsors and collaborators

Lead sponsor

Younes Oujidi

Other

Registry information

Official study title

An Observational Study About a Case of Pulmonary Embolism Following Viper's Bite

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 6, 2025
Registry last updated
Jun 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.